Alexander Nowak
Stock Analyst at Craig-Hallum
(2.77)
# 1,617
Out of 5,182 analysts
46
Total ratings
47.37%
Success rate
7.47%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BVS Bioventus | Maintains: Buy | $15 → $16 | $9.95 | +60.80% | 7 | Mar 6, 2026 | |
| CELC Celcuity | Maintains: Buy | $96 → $108 | $120.07 | -10.05% | 3 | Nov 13, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $7.48 | +194.12% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $200.17 | -21.57% | 4 | Nov 13, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $12.02 | +374.21% | 6 | Sep 5, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $21.91 | -31.54% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $6.22 | +28.62% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $1.23 | +1,363.41% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $18.63 | +168.38% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $280 → $160 | $7.40 | +2,062.16% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.75 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $1.86 | +491.40% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $53.51 | +105.57% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $7.18 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $0.85 | +35,219.05% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $10.18 | +175.05% | 1 | Aug 31, 2020 |
Bioventus
Mar 6, 2026
Maintains: Buy
Price Target: $15 → $16
Current: $9.95
Upside: +60.80%
Celcuity
Nov 13, 2025
Maintains: Buy
Price Target: $96 → $108
Current: $120.07
Upside: -10.05%
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $7.48
Upside: +194.12%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $200.17
Upside: -21.57%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $12.02
Upside: +374.21%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $21.91
Upside: -31.54%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $6.22
Upside: +28.62%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $1.23
Upside: +1,363.41%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $18.63
Upside: +168.38%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $280 → $160
Current: $7.40
Upside: +2,062.16%
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $4.75
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $1.86
Upside: +491.40%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $53.51
Upside: +105.57%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $7.18
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $0.85
Upside: +35,219.05%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $10.18
Upside: +175.05%